Table 3 Correlation of validated lncRNAs with PSA patients’ characteristics (discontinuous variables)

 Male

3.03 (1.62–4.18)

2.03 (1.23–2.72)

2.54 (1.18–5.03)

0.63 (0.28–1.10)

0.52 (0.29–1.13)

 Female

1.92 (0.88–2.94)

2.32 (1.32–3.48)

2.68 (1.50–4.47)

0.78 (0.46–1.14)

0.95 (0.51–1.24)

 P value

0.029

0.205

0.930

0.312

0.083

 Yes

2.65 (1.84–4.04)

2.03 (1.21–2.88)

2.55 (1.29–3.84)

0.76 (0.36–1.24)

0.91 (0.38–1.30)

 No

2.59 (1.32–3.76)

2.28 (1.33–3.39)

2.60 (1.23–4.87)

0.71 (0.29–1.08)

0.56 (0.34–1.13)

 P value

0.517

0.255

0.474

0.762

0.299

 Vulgaris

2.68 (1.52–3.90)

2.27 (1.25–3.04)

2.55 (1.38–4.55)

0.76 (0.30–1.12)

0.64 (0.35–1.15)

 Others

1.80 (1.19–3.68)

1.81 (1.30–3.28)

2.59 (0.47–7.88)

0.53 (0.26–1.06)

0.43 (0.34–0.64)

 P value

0.351

0.547

0.984

0.547

0.244

 Peripheral

2.66 (1.56–3.97)

2.23 (1.53–2.98)

2.47 (1.18–4.56)

0.62 (0.28–1.03)

0.64 (0.38–1.21)

 Axial

1.92 (0.94–3.51)

2.26 (0.90–3.28)

2.68 (1.31–4.80)

0.76 (0.56–1.40)

0.64 (0.34–1.06)

 Mixed

3.05 (0.98–4.85)

1.79 (0.99–3.81)

3.26 (2.08–5.48)

1.10 (0.97–1.57)

0.47 (0.24–0.88)

 P value

0.461

0.766

0.718

0.056

0.522